Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
She is a graduate of Rider University, where she acquired a Bachelors of Art in journalism, as well as a graduate of Temple University, where she received her Masters of Science in Sports Management.
Follow Kristie on Twitter at @KristieLKahl, or email her at kkahl@mjhlifesciences.com.
Advocate Discusses Types of Support for End-Stage Cancer Available for Patients and Their Loved Ones
April 11th 2022As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, from Cancer Hope Network, about seeking support for patients who may be nearing end of life, as well as support for family and friends after a loved one has passed.
Patient Offers Advice on Advocating for Quality of Life, Second Opinions in Metastatic Breast Cancer
April 1st 2022In CURE’s Speaking Out video series, on behalf of Living Beyond Breast Cancer, Myra Camino discusses her experience as a patient advocating for herself after her stage 4 metastatic breast cancer diagnosis.
Long-Term Care of Myeloma May Not Be ‘One-Stop-Shop,’ Multidisciplinary Approach Can Help
March 3rd 2022As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps, about treating myeloma as a chronic disease and how the multidisciplinary approach to care can assist in challenges, like financial toxicity.
Combatting an Isolating Disease: An Expert Offers Lung Cancer Resources for Patients, Caregivers
January 4th 2022Susan Smedley, national manager of community fundraising and endurance events at GO2 Foundation for Lung Cancer, offers resources for patients with lung cancer and their loved ones, as well as ways to get involved in the community.
While QOL Preferences Can Be Different, Lung Cancer Resources Can Match Patient Needs
January 4th 2022Susan Smedley, national manager of community fundraising and endurance events at GO2 Foundation for Lung Cancer, discusses quality of life in lung cancer, and ways patients can communicate preferences to their health care providers.
Understanding the Importance of NCCN Guidelines in Metastatic TNBC
December 15th 2021As part of its Speaking Out video series, CURE spoke with Dr. Rebecca Moroose, from Orlando Health Cancer Institute, and Dr. Virginia G. Kaklamani, from UT Health San Antonio, about the National Comprehensive Cancer Network guidelines and what they mean for patients.